0000899243-22-034834.txt : 20221102 0000899243-22-034834.hdr.sgml : 20221102 20221102203636 ACCESSION NUMBER: 0000899243-22-034834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: De Rosch Mark CENTRAL INDEX KEY: 0001890320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 221355837 MAIL ADDRESS: STREET 1: C/O AURA BIOSCIENCES, INC. STREET 2: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-31 0 0001501796 Aura Biosciences, Inc. AURA 0001890320 De Rosch Mark C/O AURA BIOSCIENCES, INC. 80 GUEST STREET BOSTON MA 01235 0 1 0 0 Chief Operating Officer Common Stock 2022-10-31 4 S 0 1115 12.4574 D 16385 D The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Julie Feder, as Attorney-in-Fact 2022-11-02